MJNA – Medicinal Marijuana

Medicinal Marijuana Is on The Verge of Rebound

Medicinal Marijuana, Inc. (OTCPK:MJNA) shut today at $0.10, an ascent of 376% since the stock shut at $0.063 on Oct 14, 2016. With almost 2.95 Billion shares extraordinary, it now has a market capitalization of $667.8 Million, which in view of MJNA’s basics and fleeting prospects, is a few times too high, verging on the silly.

MJNA’s sharp ascent in the stock cost in the course of recent weeks is likely because of most recent recreational cannabis votes in California, Arizona, Maine, Massachusetts, and Nevada, these activities go into law. This is on the grounds that MJNA is principally an organization that offers items in light of CBD (Cannabidiol) separated from modern hemp stalks and seeds, and has expressed that until pot is governmentally legitimate, it won’t offer items that incorporate THC (Tetrahydrocannabinol,) and still states on its site that it doesn’t offer items that damage the U.S. Controlled Substances Act. MJNA is a very well known pot stock.

Indeed, even the entry of restorative cannabis laws in North Dakota, Montana, Arkansas and Florida could be a negative for MJNA, in light of the fact that since the organization has practical experience in CBD removed from the stalks and seeds of modern hemp, it’s totally conceivable that it could lose piece of the overall industry to contenders that concentrate it from the buds of high-CBD strains of pot, for example, Charlotte’s Web (since renamed as therapeutic hemp).  The company is one of many penny stocks hoping to hit it big once federal legalization takes place.

Restorative Marijuana’s financials are expected in the following week, yet as of the end of 2Q/16, they positively were not the sort of numbers that would warrant an almost $700M advertise top. For the initial six months of 2016, MJNA reported aggregate income of $3.26M, which was down 42.6% from the $5.8M reported in 1H/15. The Net Operating Loss in the main portion of 2016 was roughly $1.5M, and because of different one-time charges and compose downs, the 1H/16 net misfortune was about $15M.

Charlotte’s Web Holdings (TSX:CWEB) (OTCQX:CWBHF) Fails To Impress Markets

Charlotte’s Web Holdings (TSX:CWEB) (OTCQX:CWBHF) released its quarterly results on Thursday, but the stock ended the day at the level at which it had started. It came as a surprising turn of events considering the fact that many cannabis stocks and the wider market recorded gains yesterday.

Key Metrics

The company, which is primarily focussed on the CBD space, posted revenues of $21.5 million in the fiscal first quarter. It was a disappointing performance for the company since it reflected a year on year decline from the $21.7 million it posted in Q1 2019. The revenues declined sequentially as well.

On the other hand, it should also be mentioned that analysts had projected revenues of $20.8 million for the quarter, and the CBD specialist actually managed to beat it. However, CWH managed to reduce its losses to $11.5 million for the quarter from $18.8 million in the previous quarter.

That being said, it is a far cry from the $2.5 million profit that the company had posted in the prior-year period. The net loss per share came in at $0.11 per share, which was worse than analysts’ expectations of $0.06 per share net loss in the quarter.

The better than expected performance on the revenues front came as a pleasant surprise, and CWH credited it’s online direct to consumer platform for it. More importantly, CWH also stated in its press release yesterday that is expected that sales, through its direct to consumer platform, are going to rise further in the first half of this year.

On year on year basis, sales through online channels grew by as much as 30%, and the company would hope that it continues to grow over the coming quarters. Another important factor in CHW’s immediate future is its acquisition of CBD peer Abacus Health. The deal is worth $70 million, and it is believed it is going to be completed either in this quarter or the next one.